XML 40 R22.htm IDEA: XBRL DOCUMENT v3.22.4

Stockholders’ Equity (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2022

Dec. 31, 2021

Equity [Abstract]

Schedule of Sale of Equity or Issued

During the nine months ended September 30, 2022, the Company issued:

Schedule of Sale of Equity or Issued

Issuance		Shares				Value $
Public offering(1)			1,409,771				10,031,415
Notes payable			147,500				588,524
Warrant exercises(2)			2,267,551				590,574
Common stock payable			839				16,340
Preferred Share and Dividends Payable(3)			437,327				402,068

	(1)	Value is net of $1,407,262 of fees associated with the issuances.
	(2)	Includes 197,273 broker warrants exercised on a cashless basis for 180,280 shares of common stock and warrants to purchase 1,409,771 shares of common stock exercised as part of the Company’s initial public offering.
	(3)	Includes 336,810 shares of common stock issued upon conversion of 1,213 Preferred Shares and 100,517 common shares to settle dividends payable balance.

Schedule Of Stock Options, Valuation Assumptions

The estimated fair values of the liability measured on a recurring basis are as follows:

 Schedule Of Stock Options, Valuation Assumptions 

		December 31,
		2021
Expected average volatility			85.5	%
Dividend yield			8.5	%
Expected life			2.33 Years
Risk-free interest rate			0.73	%

For the year ended December 31, 2021, and 2020, the estimated fair values of the liability measured on a recurring basis are as follows:

Schedule Of Stock Options, Valuation Assumptions

		December 31,				December 31,
		2021				2020
Expected average volatility			85.5	%			69.8	%
Dividend yield			8.5	%			8.5	%
Expected life			2.33 Years				3.33 Years
Risk-free interest rate			0.73	%			0.17	%

Schedule of Warrants Activity

A continuity schedule of the Series A Preferred Stock warrants is set forth below:

 Schedule of Warrants Activity

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Life (years)
Outstanding, December 31, 2020			48,532			$	24.98				3.33
Granted			-				-				-
Forfeited			-				-				-
Exercised			-				-				-
Outstanding and Exercisable, December 31, 2021			48,532			$	24.98				2.33
Granted			-				-				-
Forfeited			-				-				-
Exercised			(48,532	)			24.98				-
Outstanding and Exercisable, September 30, 2022			-			$	-				-

A continuity schedule of the common stock warrants is set forth below:

		Number of Warrants				Weighted Average Exercise Price
Outstanding, December 31, 2021			-			$	-
Granted			2,304,544				2.89
Forfeited			-				-
Exercised(1)			(2,284,544	)			2.89
Outstanding and Exercisable, September 30, 2022			20,000			$	2.50

(1) Includes 197,273 warrants exercised on a cashless basis for 180,280 common stock.

A continuity schedule of the Series A Preferred Stock warrants is set forth below:

Schedule of Warrants Activity

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Life (years)				Intrinsic Value
Outstanding, December 31, 2019			48,532			$	24.98				4.33			$	-
Granted			-				-				-
Forfeited			-				-				-
Exercised			-				-				-
Outstanding, December 31, 2020			48,532				24.98				3.33				-
Granted			-				-				-
Forfeited			-				-				-
Exercised			-				-				-
Outstanding and Exercisable, December 31, 2021			48,532			$	24.98				2.33			$	-

Schedule of Restricted Stock Units (RSUs)

A continuity schedule of the Restricted Stock Units (RSUs) is set forth as follows:

Schedule of Restricted Stock Units (RSUs)

		Number of RSU				Weighted Average Exercise Price				Weighted Average Life (years)
Outstanding, December 31, 2020			61,884			$	23.76				4.33
Granted			-								-
Forfeited			(2,702	)			27.76				-
Exercised			-				-				-
Outstanding, December 31, 2021			59,182			$	23.57				3.33
Granted			-				-				-
Forfeited			-				-				-
Exercised			-				-				-
Outstanding, September 30, 2022			59,182			$	23.57				2.58
Exercisable, September 30, 2022			58,813			$	23.74				2.58

A continuity schedule of the Restricted Stock Units (RSU) follows:

Schedule of Restricted Stock Units (RSUs)

		Number of RSU				Weighted Average Exercise Price				Weighted Average Life (years)
Outstanding, December 31, 2019			60,169			$	24.02				-
Granted			4,417				22.64				-
Forfeited			(2,702	)			27.76				-
Exercised			-				-				-
Outstanding, December 31, 2020			61,884				23.76				4.33
Granted			-								-
Forfeited			(2,702	)			27.76				-
Exercised			-				-				-
Outstanding, December 31, 2021			59,182			$	23.57				3.33
Exercisable, December 31, 2021			43,056			$	23.93				3.33

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration